Peter Ilonczai

Nyiregyhaza, SZ, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Impact of thromboplastin reagents on monitoring INR in a patient with triple-positive antiphospholipid syndrome: a case report.

Impact of thromboplastin reagents on monitoring INR in a patient with triple-positive antiphospholipid syndrome: a case report.

Journal: Frontiers in immunology

Published: March 10, 2025

How we treat severe inherited antithrombin deficiency: lessons from cases homozygous for the Budapest 3 variant.

How we treat severe inherited antithrombin deficiency: lessons from cases homozygous for the Budapest 3 variant.

Journal: Journal of thrombosis and haemostasis : JTH

Published: November 19, 2024

Clinical and Molecular Characterization of Nine Novel Antithrombin Mutations.

Clinical and Molecular Characterization of Nine Novel Antithrombin Mutations.

Journal: International journal of molecular sciences

Published: February 09, 2024

Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.

Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.

Journal: The journal of pathology. Clinical research

Published: July 26, 2023

High penetrance of inferior vena cava system atresia in severe thrombophilia caused by homozygous antithrombin Budapest 3 variant: Description of a new syndrome.

High penetrance of inferior vena cava system atresia in severe thrombophilia caused by homozygous antithrombin Budapest 3 variant: Description of a new syndrome.

Journal: American journal of hematology

Published: April 26, 2021

Successful treatment of acquired haemophilia A

Successful treatment of acquired haemophilia A

Journal: Orvosi hetilap

Published: March 11, 2021

Screening and monitoring of the BTKC481S mutation in a real-world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy.

Screening and monitoring of the BTKC481S mutation in a real-world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy.

Journal: British journal of haematology

Published: January 25, 2021

Investigation and treatment of prefibrotic/early primary myelofibrosis. A case study

Investigation and treatment of prefibrotic/early primary myelofibrosis. A case study

Journal: Orvosi hetilap

Published: April 11, 2018

A decade-long clinical experience on the prophylactic use of activated prothrombin complex concentrate in acquired haemophilia A: a case series from a tertiary care centre.

A decade-long clinical experience on the prophylactic use of activated prothrombin complex concentrate in acquired haemophilia A: a case series from a tertiary care centre.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: February 24, 2018

Clinical and laboratory characteristics of antithrombin deficiencies: A large cohort study from a single diagnostic center.

Clinical and laboratory characteristics of antithrombin deficiencies: A large cohort study from a single diagnostic center.

Journal: Thrombosis research

Published: July 27, 2017

Antithrombin Debrecen (p.Leu205Pro) - Clinical and molecular characterization of a novel mutation associated with severe thrombotic tendency.

Antithrombin Debrecen (p.Leu205Pro) - Clinical and molecular characterization of a novel mutation associated with severe thrombotic tendency.

Journal: Thrombosis research

Published: December 28, 2016

Evaluation of flow cytometric HIT assays in relation to an IgG-Specific immunoassay and clinical outcome.

Evaluation of flow cytometric HIT assays in relation to an IgG-Specific immunoassay and clinical outcome.

Journal: Cytometry. Part B, Clinical cytometry

Published: October 21, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026